Axsome Therapeutics (AXSM) Current Taxes (2024 - 2026)

Axsome Therapeutics has disclosed Current Taxes across 3 years of filings, most recently posting $99000.0 for Q1 2026.

• Current Taxes for Q1 2026 came in at $99000.0, down 89.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $99000.0 (down 89.69% YoY), and the FY2025 annual result was $101000.0, down 89.48% from the prior year.
• Current Taxes came in at $99000.0 for Q1 2026 at Axsome Therapeutics, down from $101000.0 in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $960000.0 in Q4 2024 to a low of $99000.0 in Q1 2026.
• The 3-year median for Current Taxes is $493000.0 (2024), against an average of $514000.0.
• Across the five-year window, Current Taxes surged 95.12% in 2025 and plunged 89.69% in 2026, its largest moves.
• Axsome Therapeutics' Current Taxes stood at $960000.0 in 2024, then plunged by 89.48% to $101000.0 in 2025, then retreated by 1.98% to $99000.0 in 2026.
• The last three Current Taxes figures came in at $99000.0 (Q1 2026), $101000.0 (Q4 2025), and $960000.0 (Q1 2025), per Business Quant data.